Neurointerventional Devices Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

Neurointerventional Devices Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

The neurointerventional devices are used by medical professionals specialized in the domain of central nervous system (CNS). It is usually practised by neuroradiologists, neurosurgeons and neurologists exploring the endovascular approach to treat the vascular diseases of the CNS. A wide range of vascular diseases burden associated with the CNS primarily drives the usage of devices. As per the American Association of Neurological Surgeons, Stroke is the third leading cause of death in United States. About 700,000 are affected each year of which, 200,000 are the recurrent attacks cases. The consistent high volume of patients with vascular diseases approaching the healthcare facilities, increases the demand of the neurointerventional devices in a region. The direct and indirect high cost of the devices and procedure as well as stringent regulations are some of primary limitations to the growth of the studied market.

• Ischemic stroke refers to the blockade of an artery in the brain. It accounts to about 87% of all the strokes, therefore, is of primary concerns to the medical professional associated with the treatment of CNS diseases.
• The revascularization devices are a common solution of the treatment of such injuries. The Solitaire™ X Revascularization Device by the Medtronic PLC, is indicated to restore the blood flow from a large intracranial vessel in patients experiencing ischemic stroke.
• With wide range of applications linked to the arterial based diseases correction, there is significant usage of the neurointerventional devices. Thus, across all kind of diseases linked to CNS, the demand for neurinterventional devices is expected to steadily grow over the forecast period.

North America with its advanced healthcare infrastructure across majority of places, and presence of many medical devices companies well-connected with the hospitals primarily boost the growth of this market. In United States, it is estimated that atleast one stroke within every 40 seconds occurs and every four minutes, someone dies of a stroke. Approximately 87% of all strokes are ischemic strokes, in which blood flow to the brain gets blocked. Similarly, as per stated by the Brain Aneurysm Foundation, cerebral aneurysms affect an estimated 6 million Americans and are accountable for nearly half a million deaths worldwide each year, with half the victims age 50 and younger. The presence of several foundations which acts support systems for many healthcare providers associated with the treatment of CNS vascular diseases also fuels the use of neurointerventional devices market.

The companies have identified consistent growth opportunities in the treatment of endovascular based diseases via neurostimulation devices. Some of the major companies in this segment include Abbott Laboratories, Johnson & Johnson (DePuy Synthes), Medtronic plc, Stryker, Penumbra, Inc., and others.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support